secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nurix Therapeutics, Inc. (NRIX)
CIK:        0001549595
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001193125-23-069218
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nurix Therapeutics discloses minimal SVB exposure; less than 1% of cash at SVB
------------------------------------------------------------------------------

- SVB closed by California DFPI on March 10; FDIC appointed receiver.
- U.S. Treasury, Fed, FDIC: all depositors fully protected; funds accessible March 13.
- Nurix's SVB account holds less than 1% of total cash, equivalents, and marketable securities.
- Remaining cash held at other large, global financial institutions.
- Company believes exposure is immaterial and funds will be fully available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549595/000119312523069218/0001193125-23-069218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549595/000119312523069218/d484325d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-069218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer